Your browser doesn't support javascript.
loading
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes.
Njenda, Duncan T; Aralaguppe, Shambhu G; Singh, Kamalendra; Rao, Rohit; Sönnerborg, Anders; Sarafianos, Stefan G; Neogi, Ujjwal.
Affiliation
  • Njenda DT; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.
  • Aralaguppe SG; Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Singh K; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.
  • Rao R; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.
  • Sönnerborg A; Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
  • Sarafianos SG; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
  • Neogi U; Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
J Antimicrob Chemother ; 73(10): 2721-2728, 2018 10 01.
Article in En | MEDLINE | ID: mdl-30053052

Full text: 1 Database: MEDLINE Main subject: Adenine / Deoxyadenosines / HIV-1 / Reverse Transcriptase Inhibitors / Anti-Retroviral Agents Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2018 Type: Article Affiliation country: Sweden

Full text: 1 Database: MEDLINE Main subject: Adenine / Deoxyadenosines / HIV-1 / Reverse Transcriptase Inhibitors / Anti-Retroviral Agents Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2018 Type: Article Affiliation country: Sweden